Effects of Marital Status on Prognosis in Women with Infiltrating Ductal Carcinoma of the Breast: A Real-World 1: 1 Propensity-Matched Study

被引:6
|
作者
Lan, Tian [1 ]
Lu, Yunyan [2 ]
Luo, Hua [1 ]
He, Junling [1 ]
He, Jiawei [1 ]
Hu, Zujian [1 ]
Xu, Haibin [1 ]
机构
[1] Hangzhou Hosp Tradit Chinese Med, Dept Breast Surg, Hangzhou, Zhejiang, Peoples R China
[2] First Peoples Hosp Xiaoshan Dist, Dept Cardiol, Hangzhou, Zhejiang, Peoples R China
来源
MEDICAL SCIENCE MONITOR | 2020年 / 26卷
关键词
Breast Neoplasms; Marital Status; Prognosis; SEER Program; PSYCHOLOGICAL DISTRESS; CANCER; SURVIVAL; RISK; SPOUSES; HISTORY; STAGE;
D O I
10.12659/MSM.923630
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The effects of marital status on infiltrating ductal carcinoma of breast cancer (IDC) have not been studied in detail. This study investigated the impact of marital status on IDC patients. Material/Methods: SEER databases were searched from 2010 to 2015 for subjects who were married, divorced, single, and wid- owed. The influence of marital status on breast cancer-specific survival (BCSS) and overall survival (OS) of IDC patients was investigated through multivariate Cox regression analysis and Kaplan-Meier analysis. To prevent bias, propensity score matching (PSM) analysis was performed. Results: The 5-year OS was 89.6%in married patients, 84.9% in divorced patients, 83.5% in single patients, and 71.3% in widowed patients (p<0.001). The 5-year BCSS were 92.9%, 90.2%, 87.6%, and 86.4%, respectively (p<0.001). Multivariate Cox regression analysis revealed that marriage was a protective factor for patients with IDC in terms of OS (divorced: HR, 1.27; 95% CI, 1.21-1.32; p<0.001; single: HR, 1.36; 95% CI, 1.31-1.42; p<0.001; widowed: HR, 1.42; 95% CI, 1.36-1.48; p<0.001) and BCSS (divorced: HR, 1.15; 95% CI, 1.09-1.21; p<0.001; single: HR, 1.27; 95% CI, 1.21-1.33; p<0.001; widowed: HR, 1.32; 95% CI, 1.25-1.40; p<0.001). Following subgroup and PSM analysis, married patients were shown to have better OS and BCSS as opposed to divorced, single, or widowed patients. Conclusions: We identify marital status as a predictor of survival in those with IDC. Widowed patients showed the highest mortality risk.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study
    Santoni, Matteo
    Massari, Francesco
    Myint, Zin W.
    Iacovelli, Roberto
    Pichler, Martin
    Basso, Umberto
    Kopecky, Jindrich
    Kucharz, Jakub
    Buti, Sebastiano
    Rizzo, Mimma
    Galli, Luca
    Buettner, Thomas
    De Giorgi, Ugo
    Kanesvaran, Ravindran
    Fiala, Ondrej
    Grande, Enrique
    Zucali, Paolo Andrea
    Fornarini, Giuseppe
    Bourlon, Maria T.
    Scagliarini, Sarah
    Molina-Cerrillo, Javier
    Aurilio, Gaetano
    Matrana, Marc R.
    Pichler, Renate
    Cattrini, Carlo
    Buechler, Tomas
    Seront, Emmanuel
    Calabro, Fabio
    Pinto, Alvaro
    Berardi, Rossana
    Zgura, Anca
    Mammone, Giulia
    Ansari, Jawaher
    Atzori, Francesco
    Chiari, Rita
    Bamias, Aristotelis
    Caffo, Orazio
    Procopio, Giuseppe
    Bassanelli, Maria
    Merler, Sara
    Messina, Carlo
    Kueronya, Zsofia
    Mosca, Alessandra
    Bhuva, Dipen
    Vau, Nuno
    Incorvaia, Lorena
    Rebuzzi, Sara Elena
    Roviello, Giandomenico
    Zabalza, Ignacio Ortego
    Rizzo, Alessandro
    TARGETED ONCOLOGY, 2023, 18 (04) : 559 - 570
  • [32] Real-World Evidence on the Use of Endocrine Therapy for Ductal Carcinoma In Situ in Patients Treated With Breast-Conser ving Surger y Followed by Postoperative Radiation Therapy: A Brazilian Retrospective Cohort Study
    de Sousa, Cecilia Felix Penido Mendes
    Pereira, Allan Andresson Lima
    Arruda, Gustavo Viani
    Gouveia, Andre Guimaraes
    Hanna, Samir Abdallah
    Cruz, Marcelo Rocha de Sousa
    dos Anjos, Carlos Henrique
    Bevilacqua, Jose Luis Barbosa
    Alcantara Filho, Paulo
    de Moraes, Fabio Ynoe
    Marta, Gustavo Nader
    CLINICAL BREAST CANCER, 2023, 23 (08) : E499 - E506
  • [33] Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma
    Hermien Hartog
    Hugo M. Horlings
    Bert van der Vegt
    Bas Kreike
    Abderrahim Ajouaou
    Marc J. van de Vijver
    H. Marike Boezen
    Geertruida H. de Bock
    Winette T. A. van der Graaf
    Jelle Wesseling
    Breast Cancer Research and Treatment, 2011, 129 : 725 - 736
  • [34] Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma
    Hartog, Hermien
    Horlings, Hugo M.
    van der Vegt, Bert
    Kreike, Bas
    Ajouaou, Abderrahim
    van de Vijver, Marc J.
    Boezen, H. Marike
    de Bock, Geertruida H.
    van der Graaf, Winette T. A.
    Wesseling, Jelle
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (03) : 725 - 736
  • [35] Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in the Treatment of Patients with Advanced Primary Hepatocellular Carcinoma: A Retrospective, Real-World Study in China
    Chen, Xiao-Qi
    Zhao, Yun-Xia
    Zhang, Chuan-Lei
    Wang, Xin-Ting
    Zhang, Xin
    Chen, Xi
    Yuan, Chang-Wei
    Zhao, Qing
    Chen, Xin-Ju
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 1483 - 1493
  • [36] Association of hepatitis B virus DNA levels with efficacy and safety outcomes in patients with hepatitis B virus-associated advanced hepatocellular carcinoma receiving tyrosine kinase inhibitor plus anti-PD-1 antibody: a multicenter propensity-matched study
    Chen, Qing-Jing
    Lin, Kong-Ying
    Lin, Zhi-Wen
    Zhang, Bing
    Liu, Ming-Qiang
    Zhang, Jian-Xi
    Lin, Ke-Can
    Huang, Qi-Zhen
    Zhang, Jin-Yu
    You, Peng-Hui
    You, Song
    Wei, Fu-Qun
    Jiang, Ya-Bin
    Zhang, Hui
    Cheng, Zhi-Qing
    Wang, Cong-Ren
    Zeng, Yong-Yi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [37] Effect of postmastectomy radiotherapy on pT1-2N1 breast cancer patients with different molecular subtypes: A real-world study based on the inverse probability of treatment weighting method
    Ye, Shangyue
    Hu, Weixian
    MEDICINE, 2022, 101 (37) : E30610
  • [38] Effect of BRCA1/2Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence Study
    Kim, Se Ik
    Lim, Hyunji
    Kim, Hee Seung
    Chung, Hyun Hoon
    Kim, Jae-Weon
    Park, Noh Hyun
    Song, Yong-Sang
    Lee, Maria
    CANCER RESEARCH AND TREATMENT, 2023, 55 (01): : 245 - 257
  • [39] Comparing PD-L1 and PD-1 inhibitors plus bevacizumab combined with hepatic arterial interventional therapies in unresetable hepatocellular carcinoma: A single-center, real-world study
    He, Minrui
    Xie, Wa
    Yuan, Ze
    Chen, Jinbin
    Wang, Juncheng
    Fu, Yizhen
    Hu, Zili
    Meng, Qi
    Gao, Wenqing
    Hu, Dandan
    Zhang, Yaojun
    Pan, Yangxun
    Zhou, Zhongguo
    INTERNATIONAL JOURNAL OF CANCER, 2025, : 1972 - 1985
  • [40] A real-world study of tyrosine kinase inhibitors plus anti-PD-1 immunotherapy with or without chemoembolization for hepatocellular carcinoma patients with main portal vein invasion
    Song, Ze
    Wu, De-Di
    Fan, Wen-Zhe
    Wu, Min-Jiang
    Miao, Hong-Fei
    Du, Jia-Hang
    Zhang, Hao
    Jiang, Dai-Rong
    Zhang, Ying-Qiang
    ABDOMINAL RADIOLOGY, 2024, 49 (08) : 2650 - 2658